Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Arne Skerra is active.

Publication


Featured researches published by Arne Skerra.


FEBS Letters | 1997

Sequence analysis and bacterial production of the anti-c-myc antibody 9E10: the VH domain has an extended CDR-H3 and exhibits unusual solubility

Wolfram Schiweck; Britta Buxbaum; Christian Schätzlein; Hans Günther Neiss; Arne Skerra

The cDNAs for the two variable domains of the antibody 9E10 were cloned from the hybridoma cell line. A chimeric 9E10 Fab fragment was produced in E. coli under control of the tightly controlled tetracycline promoter. The functional Fab fragment was isolated in a single step via a His6‐tag, which also served for its recognition by a nickel chelate‐alkaline phosphatase conjugate. Thus, the recombinant Fab fragment permitted the immunochemical detection of the myc tag in a sandwich ELISA. The dissociation constant for the interaction with the myc tag peptide was determined as 80±5 nM by fluorescence titration. In an attempt to produce the smaller 9E10 Fv fragment it was found that its VH domain alone can be readily isolated from E. coli as a soluble protein. This unusual behaviour may be explained by the 18 amino acid‐long CDR‐H3 and could be of value in the design of `single domain antibodies.


Chemistry & Biology | 1996

A Zn(II)-binding site engineered into retinol-binding protein exhibits metal-ion specificity and allows highly efficient affinity purification with a newly designed metal ligand

AndréM. Schmidt; Holger N. Müller; Arne Skerra

BACKGROUNDnThe Zn(II)-binding site from the active center of human carbonic anhydrase II, formed by three His side chains, can be grafted onto the recombinant serum retinol-binding protein (RBP). The artificial binding site in the resulting variant RBP/H3(A) has high affinity for Zn(II) and stabilizes the protein against denaturation.nnnRESULTSnThe metal-ion specificity of the grafted Zn(II) binding site in RBP/H3(A) was investigated. Both Cu(II) and Ni(II) bound with high affinity, although the Kd values were not as low as for Zn(II) binding. Competition experiments with the chelate ligands iminodiacetic acid (IDA) and nitrilotriacetic acid (NTA) suggested that both Ni(II) and Cu(II) bound to the protein in an octahedral manner with three vacant coordination sites, as previously observed for Zn(II). A substituted pyrrolidine-dicarboxylic acid was designed as a structurally rigid IDA compound and coupled to a matrix. Using this support in an immobilized metal affinity chromatography (IMAC), RBP/H3(A) was purified from the bacterial cell extract in one step with unprecedented efficiency.nnnCONCLUSIONSnAlthough the His3 metal-binding site used here had been removed from the substrate pocket of an enzyme and exposed to solvent on a protein surface, it showed clear selectivity for Zn(II) compared to Cu(II) and Ni(II). Thus the properties of this structurally defined metal-binding site (which are not shared by isolated His residues or flexible oligo-His tags) can be preserved when it is added to proteins. An IMAC matrix with improved behaviour was designed, allowing highly selective purification of RBP/H3(A) and of His6-tagged RBP as well. Such rational design of supramolecular recognition may be generally useful in the fields of protein engineering and drug design.


Archive | 1987

Structure and Dynamics of One Dimensional Ionic Solutions in Narrow Transmembrane Channels — A Molecular Dynamics Simulation Study —

Jürgen Brickmann; Arne Skerra

Molecular dynamics studies for the voltage driven transport of the alkali metal ions Li+, Na+ and K+ through gramicidin A-type channels in the presence of water molecules are presented. It is demonstrated that the number of water molecules in the channel plays a key role for the cation selectivity.


Protein Engineering | 1997

Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification.

Selma Voss; Arne Skerra


Protein Engineering | 2002

An engineered IN-1 Fab fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity

M. Fiedler; C. Horn; C. Bandtlow; M.E. Schwab; Arne Skerra


Protein Science | 2008

Glutathione S-transferase can be used as a C-terminal, enzymatically active dimerization module for a recombinant protease inhibitor, and functionally secreted into the periplasm of Escherichia coli

Tatjana Tudyka; Arne Skerra


FEBS Journal | 1996

The Escherichia Coli‐Derived Fab Fragment of the IgM/κ Antibody IN‐1 Recognizes and Neutralizes Myelin‐Associated Inhibitors of Neurite Growth

Christine E. Bandtlow; Wolfram Schiweck; Hsin-Hsiung Tai; Martin E. Schwab; Arne Skerra


Journal of Molecular Biology | 1997

The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment.

Wolfram Schiweck; Arne Skerra


Biochemical and Biophysical Research Communications | 1999

Intracellular expression of a cloned antibody fragment interferes with hepatitis B virus surface antigen secretion.

Jasper zu Putlitz; Arne Skerra; Jack R. Wands


Archive | 1997

Muteins of streptavidin

Arne Skerra; Selma Voss

Collaboration


Dive into the Arne Skerra's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge